界面新闻记者 |
界面新闻编辑 | 谢欣
zai10yue28rizhi31riliandie4ri、shizhizhengfayue150yigangyuanhou,guoneichuangxinyaogongsixindashengwuyu11yue3riwanfabugonggaocheng,zhongzhilostrancosyufortvitazhijianderengouxieyi,jizhongzhi10yue25rifabudejianyirengoushixiang。
公告中,信达生物重申对发展国际业务的积极愿景,并称由于宣布建议认购事项以来,收到股东对该提案的反馈及不同看法,youcijuedingbujixujinxinggaijiaoyi。keweiqianhoumaodundeshi,gongsicheng,zhongzhijianyirengoushixianggongpingheli,gengweifuhegongsijiqigudongdezhengtiliyi。
zai11yue4ripanqiandeyewugengxinshuominghuishang,xindashengwucfoyoufeihaicheng,fortvitajinqimeiyourongzijihua,gongsiyeyuanyiduotingqutouzirenyijian,xuanzegengrongyibeitouzirenlijiehejieshoudefangshi,chixuzhichiguojihuafazhan。
11yue4rikaipan,xindashengwugujiagaozhang,jiezhifagaobao38.200gangyuan/gu,zhang8.99%,dangxiashizhi625yigangyuan。
shijishang,fortvitachengliyu2021nian,shixindashengwudeguojihuayewupingtai,xianyiyongyouxindashengwubufenguanxiandehaiwaiquanyi,zheixieguanxiandeguoneiquanyizeliuzaiguoneishiti。xindashengwuyizhouneidegujiatiaoshuihehuishengjunyuqirengoushixiangyouguan。
10yue25ri,xindashengwushoucigongbugaijiaoyi。jianeryanzhi,qiyougongsidongshizhangjianceoyudechaodengguanliceng,tongguolostrancosxiangxindashengwuquanzizigongsifortvitazengzi,rengouhouzhefaxingjichushoude1280.83wanguxinpre-axilieyouxiangu,rengoujiawei2050wanmeiyuan。
danzuoweifortvitaguzhijichudeshichangjiazhicaiyongzichanjichufapinggu。youci,yudechaodengrenhuodexindashengwuchuhaipingtaiyue20%guquan,shiyiqijingzichandejiazhigoude,0yijia,qieweilaikeyitongguogaichuhaipingtaidandurongzi、zhijietaoxian。
zheiyinqitouzizheqiangliezhiyi,renweigaijiaoyi“jianmai”leyoujiazhidezigongsi,yejiushiqinhailetamendeliyi。
duici,gongsizai10yue29rideyewugengxinshuominghuishangduocibiaoshi,fortvitazichanchuyufeichangzaoqijieduan,shangweihuodemeiguoshiyaojianju(fda)renkedepoc(gainianyanzheng),cunzaijiaodafengxian。huaneryanzhiqianshuguzhigongyunheli。
danshichangshengyinyeqiangdiao,fortvitayongyouxindashengwudangxiazuishouguanzhudejigezichan。zaishijiezhishichanquanzuzhi(wipo)shujukujiansuokejian,fortvitazuoweishenqingren,shenqinglexindashengwuclaudin18.2/cd3shuangkang(ibi389)、claudin18.2 adc(kangtioulianyao,ibi343)、pd-1/il-2shuangkang(ibi363)dengguanxiandexiangguanzhuanli。zheixieguanxianjunshoushichangguanzhu。
juxindashengwu2024nianzhongbaocailiaohebenciyudechaodejieshao,qianshusantiaoguanxianjunshuyuzhongliulingyu。qizhong,ibi363weixindashengwudetongleishouchuangchanpin,fugaiio(zhongliumianyizhiliao)naiyaofeiai、heisesuliu、changaideng。qi2024niangongbude1qishiyanshujupoweiliangyan,meiguo2qilinchuangzhengzaijinxingzhong。9yue,qiheisesuliushiyingzhenghaihuofdakuaisutongdaozige。
lingwai,ibi343yizaizhongguoqudeweiaidepocshuju,danqizuiyoujiazhideshiyixianaishiyingzheng,qishujuhaibuchengshu。ibi389tongyangshejiweiaiheyixianai,linchuang1qishujuyiduchu。
shijishang,jiyuzhongmeishichangyaojiacunzaijiaodachaju、guoneizhifutianhuabanjiaodi,chuhaichengweiguoneichuangxinyaogongsidequshi,yezhengshibaokuoqianshuguanxianzaineidechuangxinchanpinzhichengqixindashengwudeguojihuabujuhegongsiguzhi。
lingwai,10yue30ri,xindashengwugengxindisanjiduyeji。dangqi,gongsichanpinshouruchao23yiyuan,tongbizengzhangchao40%。youci,xindashengwu2024nianqiansanjiduchanpinyingshouda61.11yiyuan,yichaoguo2023nian57.28yiyuandequannianshuiping。
本次会上,俞德超还提到,截至2025年信达生物预计上市四款重要产品,先后分别为与奥赛康合作的利厄替尼(egfr-tki)、tituoyoudankang (igf-1r) 、mashidutai(glp-1r/gcgr)dejianzhongshiyingzheng、pikangqibaidankang(il-23p19),bingzaicihoumeinianzhishaonengbaozhengliangsangechanpinshangshishangyehua,weigongsiyewuchixufazhantigongbangzhu。
评论